Science and Research
Clinical trials research
CERA conducts leading clinical trials across a variety of eye conditions, including diabetic eye disease, age-related macular degeneration, glaucoma, uveitis, inherited retinal diseases as well as other less common eye diseases.
Our research teams are made up of more than 50 eye doctors, study coordinators, scientists, and nurses supported by biostatisticians and data managers. We collaborate with research organisations, universities, pharmaceutical companies and biotech enterprises from around the world.
Why this research is important
Clinical trials play a critical role in helping develop new treatments for eye disease, and ensuring they are safe, effective and make a difference for patients.
These trials lead to breakthroughs in medical understanding, and better ways to help people keep their sight.
Associate Professor Zhichao Wu
Associate Professor Zhichao Wu is a clinician-scientist who leads CERA’s clinical biomarkers research, whose research focuses on expediting the discovery of new treatments and prevention of irreversible vision loss from conditions such as age-related macular degeneration and glaucoma.